Practice of Deep Venous Thrombosis Prophylaxis and Its Incidence in Patients Undergoing Gastrointestinal and Hepatobiliary Surgery

Maharajgunj Medical Campus1,530 enrolled

Overview

Recent studies from Asia have reported a wide variation in the incidence of deep vein thrombosis (DVT), ranging from 5% to 50% in patients undergoing major abdominal surgery. However, data specific to the Nepalese population remains unavailable. This study aims to evaluate current thromboprophylaxis practices and determine the incidence of DVT in Nepalese adults undergoing gastrointestinal and hepatobiliary surgery.

Study Type

OBSERVATIONAL

Enrollment

1,530

Conditions

Gastrointestinal

Interventions

major gastrointestinal or hepatobiliary surgery under general anesthesiaPROCEDURE

major gastrointestinal or hepatobiliary surgery under general anesthesia

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adults aged \>18 years * Underwent major gastrointestinal or hepatobiliary surgery * Surgery performed under general anesthesia * Major surgery defined as any operative intervention in the abdominal or hepatobiliary region requiring general anesthesia Exclusion Criteria: * History of VTE within 3 months before surgery * Known hypercoagulable state or congenital thrombophilia * Diagnosis of atrial fibrillation * Undergoing systemic cancer chemotherapy or radiotherapy within the past 15 days * Pregnant or lactating women * Missing information in clinical records * Non-operated patients or those receiving conservative management * Patients undergoing liver transplantation

Locations (1)

Maharajgunj Medical Campus

Kathmandu, Nepal

Outcomes

Primary Outcomes

Use of Thromboprophylaxis and Incidence of DVT in Major GI and Hepatobiliary Surgeries

This outcome assesses the proportion of patients receiving appropriate thromboprophylaxis, as well as the incidence of deep vein thrombosis (DVT) among individuals undergoing major gastrointestinal and hepatobiliary surgeries. Data will be collected to evaluate adherence to prophylaxis guidelines and to determine the effectiveness of thromboprophylactic measures in preventing DVT in this surgical population.

Time frame: From date of surgery until hospital discharge or up to 30 days postoperatively, whichever occurs first

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.